Thermo Fisher Scientific Inc. (TMO) Holdings Lifted by AGF Investments Inc.

AGF Investments Inc. raised its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 28.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 116,053 shares of the medical research company’s stock after buying an additional 25,923 shares during the quarter. AGF Investments Inc.’s holdings in Thermo Fisher Scientific were worth $22,036,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Beach Investment Management LLC. boosted its position in shares of Thermo Fisher Scientific by 1,702.8% during the 2nd quarter. Beach Investment Management LLC. now owns 71,661 shares of the medical research company’s stock valued at $12,503,000 after acquiring an additional 67,686 shares during the last quarter. CI Investments Inc. boosted its position in shares of Thermo Fisher Scientific by 10.1% during the 2nd quarter. CI Investments Inc. now owns 768,000 shares of the medical research company’s stock valued at $133,993,000 after acquiring an additional 70,200 shares during the last quarter. LA Financiere DE L Echiquier boosted its position in shares of Thermo Fisher Scientific by 7.1% during the 2nd quarter. LA Financiere DE L Echiquier now owns 30,000 shares of the medical research company’s stock valued at $5,234,000 after acquiring an additional 2,000 shares during the last quarter. Vantage Investment Advisors LLC boosted its position in shares of Thermo Fisher Scientific by 33.6% during the 2nd quarter. Vantage Investment Advisors LLC now owns 14,316 shares of the medical research company’s stock valued at $2,498,000 after acquiring an additional 3,602 shares during the last quarter. Finally, CI Global Investments Inc. bought a new stake in shares of Thermo Fisher Scientific during the 2nd quarter valued at about $28,891,000. 86.11% of the stock is owned by institutional investors and hedge funds.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $203.50 on Wednesday. The firm has a market capitalization of $81,600.00, a P/E ratio of 36.34, a P/E/G ratio of 1.47 and a beta of 1.11. Thermo Fisher Scientific Inc. has a 12-month low of $151.74 and a 12-month high of $226.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.35 and a quick ratio of 0.92.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.13. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.72 billion. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. Thermo Fisher Scientific’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.41 EPS. analysts expect that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be paid a $0.17 dividend. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend is Wednesday, March 14th. Thermo Fisher Scientific’s payout ratio is 10.71%.

A number of analysts have recently issued reports on TMO shares. Deutsche Bank set a $226.00 price target on Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, October 26th. Zacks Investment Research downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, October 30th. Leerink Swann reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Monday, October 30th. Evercore ISI started coverage on Thermo Fisher Scientific in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price target for the company. Finally, BTIG Research started coverage on Thermo Fisher Scientific in a research report on Friday, January 5th. They set a “buy” rating and a $230.00 price target for the company. Two investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Thermo Fisher Scientific presently has an average rating of “Buy” and an average price target of $220.50.

In other Thermo Fisher Scientific news, SVP Gregory J. Herrema sold 33,327 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $219.70, for a total value of $7,321,941.90. Following the transaction, the senior vice president now directly owns 60,471 shares of the company’s stock, valued at approximately $13,285,478.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $191.74, for a total value of $9,587,000.00. Following the completion of the transaction, the chief executive officer now directly owns 302,577 shares in the company, valued at $58,016,113.98. The disclosure for this sale can be found here. Insiders sold a total of 94,327 shares of company stock worth $19,260,542 over the last ninety days. Insiders own 0.49% of the company’s stock.

WARNING: “Thermo Fisher Scientific Inc. (TMO) Holdings Lifted by AGF Investments Inc.” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/14/thermo-fisher-scientific-inc-tmo-holdings-lifted-by-agf-investments-inc.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply